BAR-VAC provides 7- or 8-way clostridial disease protection with the option for Clostridium perfringens Types C and D and tetanus protection. It meets BQA guidelines for subcutaneous administration. By using Bar-Vac, producers can help eliminate the chance of tissue damage, common with intramuscular injections, and rest easy knowing that they're controlling the clostridial disease with this proven formulation.